Profile data is unavailable for this security.
About the company
GENinCode Plc is a United Kingdom-based polygenics company focused on the prevention of cardiovascular disease and ovarian cancer. The Company operates business units in the United Kingdom, Europe through GENinCode S.L.U, and in the United States through GENinCode U.S. Inc. Its predictive technology provides patients and physicians with preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict cardiovascular disease. The Company's core products include Cardio inCode - Score and Check - Coronary predictive/risk assessment; Thrombo inCode - Hematology, Recurrent Pregnancy Loss and Oncology, Thrombosis (blood clots) predictive/risk assessment; Lipid inCode - Familial Hypercholesterolemia Diagnosis and risk stratification, and SudD inCode - Hereditary Cardiomiopathies diagnosis, Risk assessment for sudden cardiac events.
- Revenue in GBP (TTM)2.16m
- Net income in GBP-7.02m
- Incorporated2018
- Employees36.00
- LocationGenincode PLC1 St. Peters SquareOXFORD OX4 4GPUnited KingdomGBR
- Phone+44 186 595 5847
- Websitehttps://www.genincode.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Image Scan Holdings Plc | 2.56m | -11.06k | 3.49m | 14.00 | -- | 2.51 | 37.86 | 1.36 | -0.00008 | -0.00008 | 0.0187 | 0.0102 | 1.07 | 2.38 | 5.38 | 183,209.30 | -0.4626 | -1.15 | -0.7257 | -1.77 | 50.57 | 51.36 | -0.4312 | -1.01 | 1.69 | -- | 0.00 | -- | 47.98 | -3.08 | 145.65 | -- | 40.19 | -- |
| Aptamer Group PLC | 1.04m | -7.01m | 4.42m | 54.00 | -- | 0.5402 | -- | 4.27 | -0.0804 | -0.0804 | 0.0048 | 0.0043 | 0.1648 | 3.89 | 2.68 | 19,166.67 | -111.66 | -- | -154.29 | -- | -11.88 | -- | -677.39 | -- | 2.04 | -39.28 | 0.3467 | -- | -56.59 | -- | -274.39 | -- | -- | -- |
| Surgical Innovations Group Plc | 12.01m | -509.00k | 6.06m | 101.00 | -- | 0.5783 | 24.45 | 0.5047 | -0.0005 | -0.0005 | 0.0129 | 0.0112 | 0.8032 | 2.85 | 5.89 | 118,950.50 | -3.40 | -8.19 | -4.18 | -9.94 | 28.70 | 32.51 | -4.24 | -13.31 | 1.23 | -4.45 | 0.1368 | -- | 5.94 | 1.84 | -292.80 | -- | 7.20 | -- |
| Feedback plc | 886.00k | -3.49m | 6.07m | 24.00 | -- | 0.6765 | -- | 6.85 | -0.2614 | -0.2614 | 0.0664 | 0.6726 | 0.0774 | -- | 3.74 | 36,916.67 | -30.44 | -28.58 | -32.67 | -31.74 | 90.60 | 92.61 | -393.47 | -299.13 | -- | -- | 0.00 | -- | 74.15 | 17.46 | -37.74 | -- | 56.22 | -- |
| Myhealthchecked PLC | 10.98m | -159.00k | 7.02m | 10.00 | -- | 0.8066 | 109.70 | 0.6396 | -0.0031 | -0.0031 | 0.2111 | 0.1674 | 0.8863 | 10.98 | 4.44 | 1,097,700.00 | -1.28 | -7.24 | -1.81 | -10.39 | 18.66 | 22.82 | -1.45 | -5.13 | 2.46 | -- | 0.003 | -- | -50.81 | 368.95 | -110.48 | -- | -2.00 | -- |
| Proteome Sciences plc | 4.04m | -4.08m | 7.38m | 35.00 | -- | -- | -- | 1.83 | -0.0138 | -0.0138 | 0.0137 | -0.0178 | 0.3927 | 4.69 | 4.61 | 115,285.70 | -39.69 | -1.22 | -- | -- | 2.11 | 54.53 | -101.07 | -2.20 | 0.1388 | -3.70 | 1.63 | -- | -35.37 | 10.52 | -284.38 | -- | 126.22 | -- |
| Rua Life Sciences PLC | 2.19m | -1.44m | 7.60m | 33.00 | -- | 1.06 | -- | 3.47 | -0.0551 | -0.0551 | 0.0653 | 0.1157 | 0.3168 | 4.30 | 3.91 | 66,393.94 | -20.82 | -24.63 | -22.39 | -26.81 | 81.06 | -- | -65.72 | -97.07 | 8.81 | -23.34 | 0.0514 | -- | 0.5507 | 36.46 | 28.11 | -- | 122.88 | -- |
| Cambridge Nutritional Sciences PLC | 9.77m | -328.00k | 8.21m | 94.00 | -- | 0.8479 | 25.49 | 0.8399 | -0.0015 | -0.0015 | 0.0411 | 0.0407 | 0.6908 | 5.39 | 4.62 | 103,978.70 | -2.32 | -11.43 | -2.60 | -12.98 | 61.86 | 58.79 | -3.36 | -26.72 | 5.03 | -- | 0.0151 | -- | 29.53 | 2.22 | 89.66 | -- | -53.43 | -- |
| Genedrive PLC | 272.00k | -5.00m | 10.05m | 43.00 | -- | 1.88 | -- | 36.94 | -0.0407 | -0.0407 | 0.0022 | 0.0098 | 0.0658 | -- | 1.60 | 6,325.58 | -120.84 | -97.55 | -197.86 | -128.51 | -- | -- | -1,837.50 | -797.03 | 1.36 | -7.49 | 0.0789 | -- | 12.24 | -50.95 | -10.16 | -- | 16.72 | -- |
| Genincode PLC | 2.16m | -7.02m | 11.95m | 36.00 | -- | 5.02 | -- | 5.53 | -0.0732 | -0.0732 | 0.0225 | 0.0135 | 0.2703 | 21.88 | 3.33 | 60,000.00 | -87.79 | -- | -124.10 | -- | 47.31 | -- | -324.81 | -- | 1.24 | -- | 0.1883 | -- | 51.05 | -- | -26.21 | -- | -- | -- |
| Renalytix PLC | 2.55m | -34.70m | 15.35m | 80.00 | -- | 0.6262 | -- | 6.01 | -0.4247 | -0.4247 | 0.0311 | 0.1477 | 0.0646 | 2.88 | 4.06 | 31,932.48 | -87.73 | -58.25 | -120.00 | -67.03 | 20.60 | -- | -1,358.30 | -1,904.79 | 1.71 | -9.62 | 0.397 | -- | 14.58 | -- | 18.52 | -- | -- | -- |
| Ondine Biomedical Inc | 665.55k | -7.97m | 15.54m | 43.00 | -- | 11.02 | -- | 23.35 | -0.0405 | -0.0405 | 0.0034 | 0.0051 | 0.1079 | 0.4237 | 4.74 | -- | -129.24 | -- | -193.37 | -- | 58.44 | -- | -1,198.01 | -- | 1.06 | -- | 0.206 | -- | 88.56 | -- | 25.60 | -- | -- | -- |
| Verici DX PLC | 3.25m | -3.61m | 16.37m | 19.00 | -- | 2.21 | -- | 5.03 | -0.0198 | -0.0198 | 0.0166 | 0.0305 | 0.4038 | -- | 5.71 | 232,338.60 | -44.82 | -- | -58.12 | -- | 77.06 | -- | -110.99 | -- | -- | -- | 0.0183 | -- | -- | -- | 23.43 | -- | -- | -- |
Data as of Sep 23 2024. Currency figures normalised to Genincode PLC's reporting currency: UK Pound GBX
31.83%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Octopus Investments Ltd.as of 27 Jun 2024 | 31.26m | 17.66% |
| Downing LLPas of 31 Dec 2023 | 10.64m | 6.01% |
| Maitland Asset Management (Pty) Ltd.as of 07 Feb 2024 | 8.47m | 4.78% |
| Chelverton Asset Management Ltd.as of 31 Dec 2023 | 5.65m | 3.20% |
| Santander Private Banking Gestion SA SGIICas of 30 Jun 2024 | 315.50k | 0.18% |
| West Yorkshire Pension Fundas of 31 Mar 2024 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2023 - 30 Aug 2024Source: FactSet Research Systems Inc.
